Center Laboratories, Inc. (TPEX:4123)
41.70
-0.30 (-0.71%)
Apr 2, 2026, 1:30 PM CST
Center Laboratories Company Description
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.
The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines.
It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease.
Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.
Center Laboratories, Inc.
| Country | Taiwan |
| Founded | 1959 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Su-Chi Wang |
Contact Details
Address: No. 3-2, Building H Taipei, 115 Taiwan | |
| Phone | 886 2 2655 8680 |
| Website | centerlab.com.tw |
Stock Details
| Ticker Symbol | 4123 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004123005 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Su-Chi Wang | Chief Executive Officer, Chief Investment Officer, Chief Operating Officer and Chairman |
| An-Ni Mao | Manager of Finance and Accounting Department |
| Hsiu Yueh Lin | Director of Administration Department |
| Min-Li Lien | Assistant Vice President of Legal Affairs Department |
| Jui-Pao Hsu | General President of Pharmaceutical Business |
| Ching-Yu Tang | Head of Corporate Governance |
| Chiun-Yu Lin | Plant Director |